Stephen Ray Mitchell

Insider Reports History

Location
C/O Vanda Pharmaceuticals Inc., 2200 Pennsylvania Ave., Suite 300 E, Washington, DC
Signature
/s/ Stephen Ray Mitchell
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Stephen Ray Mitchell:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Vanda Pharmaceuticals Inc. Director Common Stock 97.1K $446K $4.59 Jun 13, 2025 Direct

Insider Reports Filed by Stephen Ray Mitchell

Symbol Company Period Transactions Value $ Form Type Date Filed Role
VNDA Vanda Pharmaceuticals Inc. Jun 13, 2025 1 -$32.1K 4 Jun 16, 2025 Director
VNDA Vanda Pharmaceuticals Inc. Jun 5, 2025 1 $0 4 Jun 9, 2025 Director
VNDA Vanda Pharmaceuticals Inc. Nov 14, 2024 1 -$25.9K 4 Nov 18, 2024 Director
VNDA Vanda Pharmaceuticals Inc. May 17, 2024 2 $0 4 May 21, 2024 Director
VNDA Vanda Pharmaceuticals Inc. Aug 10, 2023 1 -$39.3K 4 Aug 11, 2023 Director
VNDA Vanda Pharmaceuticals Inc. Jun 8, 2023 2 $0 4 Jun 12, 2023 Director
VNDA Vanda Pharmaceuticals Inc. Jun 16, 2022 2 $0 4 Jun 21, 2022 Director
VNDA Vanda Pharmaceuticals Inc. Jun 13, 2022 1 -$25.6K 4 Jun 14, 2022 Director
VNDA Vanda Pharmaceuticals Inc. Sep 9, 2021 5 -$90K 4 Sep 13, 2021 Director
VNDA Vanda Pharmaceuticals Inc. Jun 15, 2021 3 -$54.7K 4 Jun 17, 2021 Director
VNDA Vanda Pharmaceuticals Inc. Jun 10, 2021 2 $0 4 Jun 14, 2021 Director